In sub-analyses for HbA1c, patients ( n = 129) with no change in dose or type of anti-diabetes drugs over the 3-year study period showed similar seasonal patterns to those for all patients, although comparison of the spring value with those in summer and autumn in 2018 did not reach statistical significance (Fig. 4 A).
← all excerpts
Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c, glycoalbumin, and low-density lipoprotein cholesterol.
1
—
—